These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22725270)

  • 1. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.
    Feng JQ; Xu ZY; Shi LJ; Wu L; Liu W; Zhou ZT
    J Oral Pathol Med; 2013 Feb; 42(2):148-53. PubMed ID: 22725270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
    Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
    Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
    Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Rao RS; Raju K L; Augustine D; Patil S
    Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell markers ALDH1 and Bmi1 expression in oral erythroplakia revisited: Implication for driving the process of field cancerization.
    Feng J; Zhou Z; Shi L; Yang X; Liu W
    J Oral Pathol Med; 2020 Jan; 49(1):96-99. PubMed ID: 31444928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.
    Wu TF; Li YC; Ma SR; Bing-Liu ; Zhang WF; Sun ZJ
    Tumour Biol; 2017 Apr; 39(4):1010428317695930. PubMed ID: 28381191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
    Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
    J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
    Abdulmajeed AA; Dalley AJ; Farah CS
    J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development.
    Feng JQ; Mi JG; Wu L; Ma LW; Shi LJ; Yang X; Liu W; Zhang CP; Zhou ZT
    Oral Oncol; 2012 Sep; 48(9):848-52. PubMed ID: 22525603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
    Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
    J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
    Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
    Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
    J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
    Matsika A; Srinivasan B; Day C; Mader SA; Kiernan DM; Broomfield A; Fu J; Hooper JD; Kench JG; Samaratunga H
    Pathology; 2015 Dec; 47(7):622-8. PubMed ID: 26517640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
    Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
    Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
    Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
    Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.
    Wu A; Luo W; Zhang Q; Yang Z; Zhang G; Li S; Yao K
    Cancer Lett; 2013 Apr; 330(2):181-9. PubMed ID: 23220285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
    Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M
    Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.